Case number 1:18-cv-01685
AstraZeneca AB et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2020 | 98 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jun 20, 2020 | 68 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jun 20, 2020 | 20 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jun 20, 2020 | 8 | Motion for Leave to Appear Pro Hac Vice (2) |
| Apr 13, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [62] Order Setting Mediation Conferences: The mediation scheduled with Judge Thynge for 5/6/20 at 10:00 a.m. is cancelled. Signed by Judge Mary Pat Thynge on 4/13/20. (cak) |
| Dec 4, 2019 | 118 | Patent/Trademark Report to Commissioner (1) |
| Dec 4, 2019 | 117 | SO ORDERED (3) Docket Text: SO ORDERED, re [116] CONSENT JUDGMENT. Signed by Judge Colm F. Connolly on 12/4/2019. (nmf) |
| Dec 4, 2019 | 118 | Consent Judgment (3) |
| Dec 4, 2019 | 118 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328; 8,143,239; 8,575,137; 7,967,011; 10,166,247. (Attachments: # (1) Consent Judgment)(nmf) |
| Dec 3, 2019 | 116 | Proposed Consent Judgment (3) Docket Text: PROPOSED CONSENT JUDGMENT by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Nov 22, 2019 | 114 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Nov 22, 2019 | 115 | SO ORDERED (2) Docket Text: SO ORDERED, re [114] Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Colm F. Connolly on 11/22/2019. (fms) |
| Nov 20, 2019 | 113 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Angela Vickers on November 22, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Nov 12, 2019 | 112 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Term for construction. (Silver, Daniel) |
| Nov 4, 2019 | 111 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Asserted Claims and Amended Infringement Contentions Against Teva Pharmaceuticals USA, Inc. and Catalent Pharma Solutions, LLC filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Joyce, Alexandra) |
| Nov 1, 2019 | 110 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Second Supplemental Objections and Responses to Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) and (2) Plaintiffs' Objections and Responses to Defendants' Third Set of Common Interrogatories to Plaintiffs (Nos. 12-18) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 31, 2019 | 109 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 11) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Joyce, Alexandra) |
| Oct 28, 2019 | 107 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Tevas First Supplemental Objections and Responses to Plaintiffs First Set of Common Interrogatories (Nos. 1-6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 28, 2019 | 108 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs First Notice of Deposition of Defendant Teva Pharmaceuticals USA, Inc. Under Federal Rule of Civil Procedure 30(b)(6) filed by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 22, 2019 | 106 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs First Supplemental Objections and Responses to Defendants First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 18, 2019 | 104 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS OBJECTIONS AND RESPONSES TO DEFENDANTS MYLAN PHARMACEUTICALS, INC., 3M COMPANY, TEVA PHARMACEUTICALS USA, INC., AND CATALENT PHARMA SOLUTIONS LLCS FIRST NOTICE OF DEPOSITION OF ASTRAZENECA AB AND ASTRAZENECA PHARMACEUTICALS LP PURSUANT TO FED. R. CIV. P. 30(b)(6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 18, 2019 | 105 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum directed to Morgan, Lewis & Bockius LLP and a subpoena ad testificandum directed to Gregory T. Lowen filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 17, 2019 | 103 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Responses and Objections to Plaintiffs' First Notice of Deposition of Defendant Catalent Pharma Solutions, LLC under Federal Rule of Civil Procedure 30(b)(6) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 16, 2019 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Teva Pharmaceuticals USA, Inc. and Catalent Pharma Solutions, LLCs Response to Plaintiffs Infringement Contentions filed by Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 16, 2019 | 102 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Response to Defendants' Invalidity Contentions filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 15, 2019 | N/A | SO ORDERED (0) |
| Oct 10, 2019 | 98 | Certification for Megan P. Keane (1) |
| Oct 10, 2019 | 99 | Redacted Document (13) Docket Text: REDACTED VERSION of [72] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 10, 2019 | 100 | Redacted Document (13) Docket Text: REDACTED VERSION of [73] Notice to Take Deposition by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 10, 2019 | 98 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Megan P. Keane - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Megan P. Keane)(Silver, Daniel) |
| Oct 9, 2019 | N/A | SO ORDERED (0) |
| Oct 9, 2019 | 95 | Claim Construction Opening Brief (30) Docket Text: Joint CLAIM CONSTRUCTION OPENING BRIEF filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 9, 2019 | 96 | Appendix (8) |
| Oct 9, 2019 | 96 | Exhibit J1 (28) |
| Oct 9, 2019 | 96 | Exhibits P1 - P11DD (450) |
| Oct 9, 2019 | 96 | Exhibits D1 - D4 (323) |
| Oct 9, 2019 | 97 | Notice (Other) (2) Docket Text: Joint NOTICE of Service of Case Compendium In Support of Joint Claim Construction Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief (Joyce, Alexandra) |
| Oct 9, 2019 | 96 | Main Document (8) Docket Text: Joint APPENDIX re (141 in 1:18-cv-01562-CFC) Claim Construction Opening Brief, (95 in 1:18-cv-01685-CFC) Claim Construction Opening Brief by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit J1, # (2) Exhibits P1 - P11DD, # (3) Exhibits D1 - D4)(Joyce, Alexandra) |
| Oct 8, 2019 | 87 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of a subpoena duces tecum on Fish & Richardson PC and a subpoena ad testificandum on Janis K. Fraser filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Oct 8, 2019 | 88 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Aleksandra Hughes on October 28, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 89 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Craig Jones on October 21, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 90 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Cherri Petrie on October 22, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 91 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of David Wilcox on October 23, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 92 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Geraldine Croke on October 30, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 93 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Nick Schuenemann on October 24, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Oct 8, 2019 | 94 | Stipulation to EXTEND Time (2) Docket Text: Joint STIPULATION TO EXTEND TIME the deadline for the Parties to submit their Joint Claim Construction Brief to Wednesday, October 9, 2019 (from Tuesday, October 8, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Joyce, Alexandra) |
| Oct 7, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kevin J. DeJong for Catalent Pharma Solutions, LLC and Teva Pharmaceuticals USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
| Oct 7, 2019 | 86 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Markman Brief filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: Per request of filer, the PDF files at D.I. nos. 72 and 73 have been removed and replaced with versions that appropriately reflect the entries are sealed. (fms) |
| Oct 4, 2019 | 77 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Domenick Fanelli on October 15. 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 78 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Nayna Govind on October 28, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 79 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Darren Hodson on October 24, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 80 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Andy Ludzik on October 21, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 81 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Maria Marlow on November 1, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 82 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jorgen Rasmussen on October 30, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 83 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Gary Rowles on October 18, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 84 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jonas Sibomana on October 17, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 4, 2019 | 85 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Frank Trudo on October 16, 2019 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 2, 2019 | 75 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals, Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs First Notice of Deposition of AstraZeneca AB and AstraZeneca Pharmaceuticals LP Pursuant to Fed. R. Civ. P. 30(b)(6) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Oct 2, 2019 | 76 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions, LLC's Third Set of Common Interrogatories to Plaintiffs (Nos. 12-18) filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Oct 1, 2019 | 74 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Second Set of Common Interrogatories to Plaintiffs (No. 11) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Sep 28, 2019 | N/A | CORRECTING ENTRY: (0) |
| Sep 23, 2019 | 71 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Reply Markman Brief and (2) Reply Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 17, 2019 | N/A | SO ORDERED (0) |
| Sep 17, 2019 | N/A | SO ORDERED (0) |
| Sep 17, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Sep 17, 2019 | 67 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Kevin J. DeJong - filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Sep 17, 2019 | 68 | Certification for Einar Stole (1) |
| Sep 17, 2019 | 69 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Dr. Anthony J. Cutie on September 18, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 17, 2019 | 70 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Robert Boyd on September 19, 2019 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Sep 17, 2019 | 68 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Einar Stole - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Einar Stole)(Silver, Daniel) |
| Sep 10, 2019 | N/A | SO ORDERED (0) |
| Sep 9, 2019 | 66 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1)Defendants Mylan Pharmaceuticals Inc., 3M Company, Teva Pharmaceuticals USA, Inc., and Catalent Pharma Solutions LLCs Answering Claim Construction Brief; (2) Declaration of Dr. Anthony J. Cutie in Support of Defendants Answering Claim Construction Brief; and (3) Declaration of Robert Boyd in Support of Defendants Answering Claim Construction Brief filed by 3M Company, Mylan Pharmaceuticals Inc..(Ewing, Alexandra) |
| Sep 6, 2019 | 65 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME (1) Service of Defendants Answering Claim Construction Brief is hereby extended to Monday, September 9, 2019 (from Friday, September 6); (2) Service of Plaintiffs Reply Claim Construction Brief is hereby extended to Monday, September 23 (from Tuesday, September 17); (3) Service of Defendants Sur-Reply Claim Construction Brief is hereby extended to Thursday, October 3 (from Friday, September 27); and (4) the deadline to file the Joint Claim Construction Brief is hereby extended to Tuesday, October 8 (from Wednesday, October 2) to - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Aug 27, 2019 | N/A | SO ORDERED (0) |
| Aug 26, 2019 | 64 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for substantial completion of document production to September 6, 2019 - filed by Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Aug 20, 2019 | 63 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Opening Markman Brief; and (2) Declaration of Cory J. Berkland, Ph.D. on Claim Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Aug 14, 2019 | 62 | Order Setting Mediation Conferences (7) Docket Text: ORDER Setting Mediation Conferences: A Mediation Conference is set for 5/6/2020 at 10:00 AM in Courtroom 2B before Judge Mary Pat Thynge. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 8/14/19. (cak) |
| Aug 8, 2019 | N/A | Remark (0) Docket Text: Remark re: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Default Word Limits for Markman Briefs - Per Judge Connolly's standing order of June 18, 2019 on His Honor's website: "The provisions regarding briefing, case dispositive motions, papers filed under seal, hard copies, motions in limine, and word limitations set forth in the April 22, 2019 revised form order for patent cases shall apply in IN ALL PATENT CASES in which the parties are represented by counsel, regardless of when the case was filed, and specifically including: (1) cases in which the Court has already entered a Scheduling Order; and (2) cases in which a Scheduling Order has not yet been entered and a party seeks to file a motion to dismiss, motion for a preliminary injunction, or other filing before the entry of a Scheduling Order." Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Aug 7, 2019 | N/A | SO ORDERED (0) |
| Aug 5, 2019 | 57 | Letter (2) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Default Word Limits for Markman Briefs - re (66 in 1:18-cv-01562-CFC) Scheduling Order,,. (Silver, Daniel) |
| Aug 5, 2019 | 58 | Claim Construction Chart (20) |
| Aug 5, 2019 | 58 | Exhibit A-E (108) |
| Aug 5, 2019 | 59 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Aug 5, 2019 | 60 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re (58 in 1:18-cv-01685-CFC, 97 in 1:18-cv-01562-CFC) Claim Construction Chart - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Cottrell, Frederick) |
| Aug 5, 2019 | 61 | Motion for Miscellaneous Relief (2) Docket Text: MOTION for Claim Construction re [58] Claim Construction Chart - filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Aug 5, 2019 | 58 | Main Document (20) Docket Text: CLAIM Construction Chart by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A-E)(Silver, Daniel) |
| Aug 2, 2019 | N/A | SO ORDERED (0) |
| Aug 2, 2019 | 56 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to: (1) submit the Joint Claim Construction Chart and (2) submit their position regarding word limits for Claim Construction briefing to Monday, August 5, 2019 (from Friday, August 2, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jul 31, 2019 | 55 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Submit the Joint Claim Construction Chart to August 2, 2019 - filed by 3M Company, Mylan Inc.. (Ewing, Alexandra) |
| Jul 29, 2019 | 54 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of PLAINTIFFS IDENTIFICATION OF INTRINSIC EVIDENCE IN OPPOSITION TO DEFENDANTS PROPOSED CONSTRUCTIONS filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 25, 2019 | 52 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Constructions and Identification of Intrinsic Evidentiary Support filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 25, 2019 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Proposed Constructions and Citations to Intrinsic Evidence for the Claim Terms and Phrases from U.S. Patent Nos. 7,759,328; 8,143,239; 8,575,137; and 10,166,247 filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jul 22, 2019 | 50 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 22, 2019 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants' First Set of Requests for the Production of Documents and Things (Nos. 1-57) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 19, 2019 | 49 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs List of Proposed Claim Terms for Construction filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 17, 2019 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Teva Pharmaceutical USA, Inc. and Catalent Pharma Solutions, LLC's Invalidity Contentions filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jul 8, 2019 | 47 | Answer to Counterclaim (19) Docket Text: ANSWER to [39] Answer to Amended Complaint,, Counterclaim, by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Jul 3, 2019 | N/A | SO ORDERED (0) |
| Jul 3, 2019 | 46 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Respond to Teva Pharmaceuticals USA, Inc.'s Counterclaims to July 8, 2019 - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 26, 2019 | 45 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 8/5/2019 at 11:30 AM before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 6/26/19. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) |
| Jun 24, 2019 | 44 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant's First Set of Common Interrogatories to Plaintiffs (Nos. 1-10) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Hoeschen, Nathan) |
| Jun 21, 2019 | 43 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants First Set of Requests for the Production of Documents and Things (Nos. 1-50) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 19, 2019 | 42 | Protective Order (23) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 6/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(fms) |
| Jun 17, 2019 | N/A | SO ORDERED (0) |
| Jun 17, 2019 | 41 | Proposed Order (23) Docket Text: PROPOSED ORDER Stipulated Protective Order by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 14, 2019 | N/A | Patent Report Notice (0) Docket Text: PATENT REPORT NOTICE: Please note that if patents are being added to this case, the filing party should complete the Report to Commissioner of Patents & Trademarks, and enter it on the docket using the PATENT/TRADEMARK REPORT event in the OTHER DOCUMENT list. The patent report form can be found at www.ded.uscourts.gov under the Clerk's Office FORMS button. (fms) |
| Jun 14, 2019 | 38 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [34] Amended Complaint [Catalent's Answer and Defenses to Plaintiffs' Second Amended Complaint for Patent Infringement] by Catalent Pharma Solutions, LLC.(Keller, Karen) |
| Jun 14, 2019 | 39 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [34] Amended Complaint [Teva's Answer, Defenses, and Counterclaims to Plaintiffs' Second Amended Complaint for Patent Infringement], COUNTERCLAIM against AstraZeneca AB, AstraZeneca Pharmaceuticals LP by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Jun 14, 2019 | 40 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the parties to Submit Proposed Protective Order to June 17, 2019 - filed by 3M Company, Mylan Pharmaceuticals Inc.. (Ewing, Alexandra) |
| Jun 11, 2019 | N/A | SO ORDERED (0) |
| Jun 10, 2019 | 37 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for the Parties to Submit Proposed Protective Order to Friday, June 14, 2019 (from Monday June 10, 2019) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Jun 4, 2019 | 36 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' Asserted Claims and Infringement Contentions Against Defendants filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| May 31, 2019 | N/A | Patent Report Notice (0) |
| May 31, 2019 | 33 | SO ORDERED (2) Docket Text: SO ORDERED, re [32] Stipulation filed by AstraZeneca Pharmaceuticals LP, AstraZeneca AB. Signed by Judge Colm F. Connolly on 5/31/2019. (fms) |
| May 31, 2019 | 34 | Amended Complaint (33) |
| May 31, 2019 | 34 | Exhibit Exhibits A-E (108) |
| May 31, 2019 | 35 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328 ;8,143,239 ;8,575,137 ;7,967,011 ;10,166,247 . (Silver, Daniel) |
| May 31, 2019 | 34 | Main Document (33) Docket Text: Second AMENDED COMPLAINT for Patent Infringement against Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc.- filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit Exhibits A-E)(Silver, Daniel) |
| May 31, 2019 | 34 | Amended Complaint* (1) |
| May 28, 2019 | 32 | Stipulation (2) |
| May 28, 2019 | 32 | Exhibit 1 (34) |
| May 28, 2019 | 32 | Exhibit 2 (34) |
| May 28, 2019 | 32 | Main Document (2) Docket Text: STIPULATION and [Proposed] Order Regarding Second Amended Complaint by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Silver, Daniel) |
| May 21, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(cak) |
| May 20, 2019 | 31 | Scheduling Order (18) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 8/30/2019. Amended Pleadings due by 8/30/2019. Fact Discovery completed by 11/1/2019. Joint Claim Construction Brief due by 10/2/2019. A Markman Hearing is set for 12/4/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. A Final Pretrial Conference is set for 6/2/2020 at 04:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 6/15/2020 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/20/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| May 17, 2019 | 29 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs AstraZeneca AB and AstraZeneca Pharmaceuticals LPs Initial Disclosures Pursuant to Rule 26(a)(1); (2) Plaintiffs Initial Disclosures Identifying Defendants Accused Products and Plaintiffs Asserted Patents; and (3) Plaintiffs Initial Disclosures Pursuant to Paragraph 3 of The Default Standard for Discovery filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| May 17, 2019 | 30 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Catalent Pharma Solutions, LLCs Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and The Delaware Default Standard for Discovery; (2) Defendant Teva Pharmaceuticals USA, Inc.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) and The Delaware Default Standard for Discovery; (3) Catalents Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-53); (4) Tevas Responses to Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-53); (5) Defendant Catalent Pharma Solutions, LLCs Response to Plaintiffs First Set of Common Interrogatories (Nos. 1-6); (6) Defendant Tevas Response to Plaintiffs First Set of Common Interrogatories (Nos. 1-6) filed by Catalent Pharma Solutions, LLC, Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| May 15, 2019 | 28 | Proposed Order (18) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Apr 17, 2019 | 27 | Notice of Service (4) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Common Interrogatories (Nos. 1-6) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Apr 15, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 4/15/2019. (Court Reporter V. Gunning.) Counsel to submit the final proposed scheduling order to the Court. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Apr 12, 2019 | 26 | Proposed Order (14) Docket Text: PROPOSED ORDER Scheduling by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Silver, Daniel) |
| Apr 10, 2019 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs First Set of Requests for Production of Documents and Things to Catalent (Nos. 1-53), (2) Plaintiffs First Set of Requests for Production of Documents and Things to Teva Pharmaceuticals (Nos. 1-53) filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Apr 9, 2019 | 24 | Letter (3) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq.. (Silver, Daniel) |
| Mar 22, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 20, 2019 | N/A | SO ORDERED (0) |
| Mar 20, 2019 | 23 | Motion for Leave to Appear Pro Hac Vice (6) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Nicholas K. Mitrokostas, Natasha E. Daughtrey, and Tyler Doh Ph.D. - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Mar 8, 2019 | 22 | Order Setting Scheduling Conference (2) Docket Text: Order Setting Scheduling Conference: A Scheduling Conference is set for 4/15/2019 at 03:00 PM in Chambers before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 3/8/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Mar 5, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Mar 5, 2019 | 21 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Daniel M. Silver, Esq. regarding Proposed Scheduling Order - re (37 in 1:18-cv-01562-CFC, 37 in 1:18-cv-01562-CFC, 19 in 1:18-cv-01685-CFC, 19 in 1:18-cv-01685-CFC) Order,, Set Deadlines,. (Silver, Daniel) |
| Feb 22, 2019 | N/A | SO ORDERED (0) |
| Feb 21, 2019 | 20 | Certifications for Douglas A. Behrens (1) |
| Feb 21, 2019 | 20 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Douglas A. Behrens - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certifications for Douglas A. Behrens)(Silver, Daniel) |
| Feb 19, 2019 | 19 | Order (2) Docket Text: ORDER, IT IS ORDERED that, on or before March 5, 2019, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/5/2019.) Signed by Judge Colm F. Connolly on 2/19/2019. Associated Cases: 1:18-cv-01562-CFC, 1:18-cv-01685-CFC(nmf) |
| Jan 18, 2019 | 18 | Answer to Counterclaim (17) Docket Text: ANSWER to [15] Answer to Amended Complaint, Counterclaim by AstraZeneca AB, AstraZeneca Pharmaceuticals LP.(Silver, Daniel) |
| Dec 28, 2018 | 14 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [10] Amended Complaint, by Catalent Pharma Solutions, LLC.(Keller, Karen) |
| Dec 28, 2018 | 15 | Answer to Amended Complaint (30) Docket Text: ANSWER to Amended Complaint, re: [10] Amended Complaint, , COUNTERCLAIM against AstraZeneca AB, AstraZeneca Pharmaceuticals LP by Teva Pharmaceuticals USA, Inc..(Keller, Karen) |
| Dec 28, 2018 | 16 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Catalent, Inc. for Catalent Pharma Solutions, LLC filed by Catalent Pharma Solutions, LLC. (Keller, Karen) |
| Dec 28, 2018 | 17 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Dec 20, 2018 | N/A | SO ORDERED (0) |
| Dec 19, 2018 | 13 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME (and proposed order) to move, plead or otherwise respond to the First Amended Complaint to December 28, 2018 - filed by Catalent Pharma Solutions, LLC. (Keller, Karen) |
| Dec 13, 2018 | N/A | SO ORDERED (0) |
| Dec 13, 2018 | 12 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the First Amended Complaint to December 28, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Nov 30, 2018 | N/A | Remark (0) |
| Nov 30, 2018 | 11 | Summons Returned Executed (3) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Catalent Pharma Solutions, LLC served on 11/30/2018, answer due 12/21/2018. (Silver, Daniel) |
| Nov 29, 2018 | 10 | Amended Complaint (28) |
| Nov 29, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Catalent Pharma Solutions, LLC on 11/29/2018. (sar) |
| Nov 29, 2018 | 10 | Exhibit A-D (85) |
| Nov 29, 2018 | 10 | Main Document (28) Docket Text: First AMENDED COMPLAINT for Patent Infringement against Teva Pharmaceuticals USA, Inc., Catalent Pharma Solutions, LLC- filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A-D, # )(Silver, Daniel) Modified on 11/30/2018 (fms). |
| Nov 29, 2018 | 10 | Amended Complaint* (1) |
| Nov 27, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Nov 16, 2018 | N/A | SO ORDERED (0) |
| Nov 16, 2018 | N/A | SO ORDERED (0) |
| Nov 15, 2018 | 8 | Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna (4) |
| Nov 15, 2018 | 9 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to Respond to the Complaint to December 3, 2018 - filed by Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Nov 15, 2018 | 8 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Certification for Christopher N. Sipes, Gary M. Rubman, Matthew Kudzin and Anna Q. Han)(Silver, Daniel) |
| Oct 31, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Oct 29, 2018 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. Teva Pharmaceuticals USA, Inc. served on 10/29/2018, answer due 11/19/2018. (Silver, Daniel) |
| Oct 26, 2018 | N/A | Summons Issued (0) |
| Oct 26, 2018 | 1 | Complaint (26) |
| Oct 26, 2018 | 1 | Exhibit A - D (85) |
| Oct 26, 2018 | 1 | Civil Cover Sheet (2) |
| Oct 26, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Oct 26, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 9/14/18. Date of Expiration of Patent: See attachment.Thirty Month Stay Deadline: 3/14/2021. (lak) |
| Oct 26, 2018 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,759,328 ;8,143,239 ;8,575,137 ;7,967,011. (lak) |
| Oct 26, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (lak) |
| Oct 26, 2018 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent AstraZeneca PLC for AstraZeneca Pharmaceuticals LP filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (lak) |
| Oct 26, 2018 | 1 | Main Document (26) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2490276.) - filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP. (Attachments: # (1) Exhibit A - D, # (2) Civil Cover Sheet)(lak) |
| Oct 26, 2018 | 1 | Complaint* (1) |
